A multiple stressor approach to study the toxicity and sub-lethal effects of pharmaceutical compounds on the larval development of a marine invertebrate

Journal of Hazardous Materials

Volumn 263, Issue , 2013, Pages 233-238

  Gonzalez Ortegon E ^a   Blasco, J ^b   Le Vay, L ^a   Gimenez L ^a  

^a BANGOR UNIVERSITY   (United Kingdom)

^b INSTITUTO DE CIENCIAS MARINAS DE ANDALUCÍA   (Spain)

Author keywords

Clofibric acid; Clotrimazole; Diclofenac sodium; Palaemon serratus; Pharmaceuticals

Indexed keywords

CLOFIBRIC ACID; CLOTRIMAZOLE; DICLOFENAC SODIUM; GROWTH AND DEVELOPMENT; MARINE INVERTEBRATES; MAXIMUM CONCENTRATIONS; PALAEMON SERRATUS; PHARMACEUTICAL COMPOUNDS;

COOLING WATER; DRUG PRODUCTS; SODIUM;

TOXICITY;

CLOFIBRIC ACID; CLOTRIMAZOLE; DICLOFENAC; SEA WATER;

BODY MASS; COASTAL ZONE; CRUSTACEAN; DRUG; GROWTH RATE; JUVENILE; LARVAL DEVELOPMENT; MARINE ECOSYSTEM; MOLT; SALINITY; SEAWATER; SUBLETHAL EFFECT; TEMPERATURE PROFILE; TOXICITY;

ARTICLE; BODY MASS; COASTAL WATERS; CONTROLLED STUDY; GROWTH; LARVAL DEVELOPMENT; LARVAL STAGE; NONHUMAN; PALAEMON; PALAEMON SERRATUS; SALINITY; SURVIVAL; TEMPERATURE;

EUROPE;

DECAPODA (CRUSTACEA); INVERTEBRATA; PALAEMON SERRATUS;

CLOFIBRIC ACID; CLOTRIMAZOLE; DICLOFENAC SODIUM; PALAEMON SERRATUS; PHARMACEUTICALS;

ANIMALS; BODY SIZE; CLOFIBRIC ACID; CLOTRIMAZOLE; DICLOFENAC; LARVA; PALAEMONIDAE; WATER POLLUTANTS, CHEMICAL;

EID: 84888200558     PISSN: 03043894     EISSN: 18733336     Source Type: Journal    
DOI: 10.1016/j.jhazmat.2013.09.041     Document Type: Article

References (42)

1. Halling-Sorensen B., Nielsen S.N., Lanzky P.F., Ingerslev F., Holten Luzhoff H.C., Jorgensen S.E. Occurrence, fate, and effects of pharmaceutical substances in the environment-a review. Chemosphere 1998, 36:357-393.
2. Rosi-Marshall E., Royer T. Pharmaceutical compounds and ecosystem function: an emerging research challenge for aquatic ecologists. Ecosystems 2012, 15:867-880.
3. Fent K., Weston A.A., Caminada D. Ecotoxicology of human pharmaceuticals. Aquat. Toxicol. 2006, 76:122-159.
4. Santos L.H.M., Araújo A.N., Fachini A., Pena A., Delerue-Matos C., Montenegro M.C.B. Ecotoxicological aspects related to the presence of pharmaceuticals in the aquatic environment. J. Hazard. Mater. 2010, 175:45-95.
5. Daughton C.G., Ternes T.A. Pharmaceuticals and personal care products in the environment: agents of subtle change?. Environ Health Persp. 1999, 107:907-938.
6. Buser H.R., Müller M.D. Occurrence of the pharmaceutical drug clofibric acid and the herbicide mecoprop in various swiss lakes and in the north sea. Environ. Sci. Technol. 1998, 32:188-192.
7. Weigel S., Kuhlmann J., Hühnerfuss H. Drugs and personal care products as ubiquitous pollutants: occurrence and distribution of clofibric acid, caffeine and DEET in the North Sea. Sci. Total Environ. 2002, 295:131-141.
8. Emblidge J.P., DeLorenzo M.E. Preliminary risk assessment of the lipid-regulating pharmaceutical clofibric acid, for three estuarine species. Environ. Res. 2006, 100:216-226.
9. Blasco J., Delvalls A. Impact of emergent contaminants in the environment: environmental risk assessment. The Handbook of Environmental Chemistry Vol 5 Part S/1. Emergent Contaminants from Industrial and Municipal Waste, Occurrence, Analysis and Effects 2008, 169-188. Springer, Berlin. D. Barceló, M. Petrovic (Eds.).
10. Thomas K.V., Hilton M.J. The occurrence of selected human pharmaceutical compounds in UK estuaries. Mar. Pollut. Bull. 2004, 49:436-444.
11. Roberts P.H., Thomas K.V. The occurrence of selected pharmaceuticals in wastewater effluent and surface waters of the lower Tyne catchment. Sci. Total Environ. 2006, 356:143-153.
12. Heberer T. Occurrence, fate, and removal of pharmaceutical residues in the aquatic environment: a review of recent research data. Toxicol. Lett. 2002, 131:5-17.
13. Hoeger B., Köllner B., Dietrich D.R., Hitzfeld B. Water-borne diclofenac affects kidney and gill integrity and selected immune parameters in brown trout (Salmo trutta f. fario). Aquat. Toxicol. 2005, 75:53-64.
14. Directive 2008/105/EC of the European Parliament and of the Council of 23 October 2000 of 16 December 2008, on environmental quality standards in the field of water policy, The European Parliament and Council, L348/84, 2008.
15. Porsbring T., Blanck H., Tjellström H., Backhaus T. Toxicity of the pharmaceutical clotrimazole to marine microalgal communities. Aquat. Toxicol. 2009, 91:203-211.
16. OSPAR-Commission OSPAR List of Chemicals for Priority Action 2006, (update 2006).
17. Peschka M., Roberts P.H., Knepper T.P. Analysis, fate studies and monitoring of the antifungal agent clotrimazole in the aquatic environment. Anal. Bioanal. Chem. 2007, 389:959-968.
18. Cleuvers M. Aquatic ecotoxicity of pharmaceuticals including the assessment of combination effects. Toxicol. Lett. 2003, 142:185-194.
19. Láng J., Kohidai L. Effects of the aquatic contaminant human pharmaceuticals and their mixtures on the proliferation and migratory responses of the bioindicator freshwater ciliate Tetrahymena. Chemosphere 2012, 89:592-601.
20. Gyllenhammar I., Eriksson H., Söderqvist A., Lindberg R.H., Fick J., Berg C. Clotrimazole exposure modulates aromatase activity in gonads and brain during gonadal differentiation in Xenopus tropicalis frogs. Aquat. Toxicol. 2009, 91:102-109.
21. Shi H., Sun Z., Liu Z., Xue Y. Effects of clotrimazole and amiodarone on early development of amphibian (Xenopus tropicalis). Toxicol. Environ. Chem. 2012, 94:37-41.
22. González-Ortegón E., Pascual E., Cuesta J.A., Drake P. Field distribution and osmoregulatory capacity of shrimps in a temperate European estuary (SW Spain). Estuar. Coast. Shelf Sci. 2006, 67:293-302.
23. González-Ortegón E., Subida M.D., Cuesta J.A., Arias A.M., Fernández-Delgado C., Drake P. The impact of extreme turbidity events on the nursery function of a temperate European estuary with regulated freshwater inflow. Estuar. Coast. Shelf Sci. 2010, 87:311-324.
24. Moore S.F., Dwyer R.L. Effects of oil on marine organisms: a critical assessment of published data. Water Res. 1974, 8:819-827.
25. Pechenik J.A., Wendt D.E., Jarrett J.N. Metamorphosis is not a new beginning larval experience influences juvenile performance. Bioscience 1998, 48:901-910.
26. Pechenik J.A. Environmental influences on larval survival and development. Reproduction of Marine Invertebrates 1987, Vol. IX:551-668. Blackwell Scientific Publications and Boxwood Press, California.
27. Santos J.L., Aparicio I., Alonso E., Callejón M. Simultaneous determination of pharmaceutically active compounds in wastewater samples by solid phase extraction and high-performance liquid chromatography with diode array and fluorescence detectors. Anal. Chim. Acta 2005, 550:116-122.
28. Bates D., Maechler M. lme4: Linear Mixed-Effects Models using S4 Classes 2009, R package version 0. 999375-32.
29. R Development Core Team R: A Language and Environment for Statistical Computing 2006, R Foundation for Statistical Computing, Vienna, Austria.
30. Flaherty C.M., Dodson S.I. Effects of pharmaceuticals on Daphnia survival, growth, and reproduction. Chemosphere 2005, 61:200-207.
31. Ferrari B., Paxéus N., Giudice R.L., Pollio A., Garric J. Ecotoxicological impact of pharmaceuticals found in treated wastewaters: study of carbamazepine, clofibric acid, and diclofenac. Ecotoxicol. Environ. Safety 2003, 55:359-370.
32. Calabrese A., Davis H.C. Tolerances and requirements of embryos and larvae of bivalve molluscs. Helgol. Wiss. Meeresunters. 1970, 20:553-564.
33. Schwaiger J., Ferling H., Mallow U., Wintermayr H., Negele R.D. Toxic effects of the non-steroidal anti-inflammatory drug diclofenac. Part I: histopathological alterations and bioaccumulation in rainbow trout. Aquat Toxicol. 2004, 68:141-150.
34. Triebskorn R., Casper H., Heyd A., Eikemper R., Köhler H.-R., Schwaiger J. Toxic effects of the non-steroidal anti-inflammatory drug diclofenac. Part II: cytological effects in liver, kidney, gills and intestine of rainbow trout (Oncorhynchus mykiss). Aquat. Toxicol. 2004, 68:151-166.
35. Hallare A.V., Köhler H.-R., Triebskorn R. Developmental toxicity and stress protein responses in zebrafish embryos after exposure to diclofenac and its solvent, DMSO. Chemosphere 2004, 56:659-666.
36. OSPAR Commission OSPAR Background Document on Clotrimazole, Hazardous Substances Series, (2005) 2005.
37. McKenney C.L., Costlow J.D. The effects of mercury on developing larvae of Rhithropanopeus harrisii (Gould). Estuar. Coast. Shelf Sci. 1982, 14:193-213.
38. Sanders B., Jenkins K. Relationships between free cupric ion concentrations in sea water and copper metabolism and growth in crab larvae. Biol. Bull. 1984, 167:704-712.
39. Laughlin R. The effects of temperature and salinity on larval growth of the horseshoe crab Limulus polyphemus. Biol. Bull. 1983, 164:93-103.
40. Pechenik J.A., Rittschof D., Schmidt A. Influence of delayed metamorphosis on survival and growth of juvenile barnacles Balanus amphitrite. Mar. Biol. 1993, 294:287-294.
41. Pechenik J.A. Delayed metamorphosis by larvae of benthic marine invertebrates: does it occur? Is there a price to pay?. Ophelia 1990, 32:63-94.
42. Giménez L. Relationships between habitat conditions, larval traits, and juvenile performance in a marine invertebrate. Ecology 2010, 91:1401-1413.